NYSE:ACHR - US03945R1023 - Common Stock
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 566.40M | 509.70M | 446.90M | 347.40M | 358.30M | |||
Research and Development | 397.10M | 347.90M | 271.10M | 169.20M | 63.40M | |||
Selling, General, and Administrative Expenses | 155.50M | 151.50M | 167.90M | 164.30M | 176.27M | |||
Operating Income | -566.40M | -509.70M | -446.90M | -347.40M | -358.30M | |||
Interest Income/Expense | 30.40M | 21.90M | 16.40M | 2.30M | -1.00M | |||
Other Income/Expense | -76.70M | -48.80M | -26.90M | 27.80M | 10.60M | |||
Non Recurring Items | N/A | N/A | 0.00 | 0.00 | 900.00K | |||
Income Before Taxes | -612.70M | -536.60M | -457.40M | -317.30M | -347.80M | |||
Income Tax | 100.00K | 200.00K | 500.00K | N/A | N/A | |||
Net Income | -612.80M | -536.80M | -457.90M | -317.30M | -347.80M | |||
EBITDA | -550.70M | -498.00M | -440.40M | -343.00M | -357.00M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.25 | -1.42 | -1.69 | -1.31 | -1.46 | |||
Non GAAP EPS | -1.27 | -1.42 | -1.25 | -0.92 | N/A | |||
Statistics |
All data in USD